Nimotuzumab Plus Gemcitabine for K-Ras Wild-Type Locally Advanced or Metastatic Pancreatic Cancer

Author:

Qin Shukui1ORCID,Li Jin2,Bai Yuxian3ORCID,Wang Zishu4,Chen Zhendong5ORCID,Xu Ruihua6ORCID,Xu Jianming7ORCID,Zhang Hongmei8ORCID,Chen Jia9,Yuan Ying10ORCID,Liu Tianshu11,Yang Lin12ORCID,Zhong Haijun13,Chen Donghui14,Shen Lin15ORCID,Hao Chunyi15,Fu Deliang16,Cheng Ying17ORCID,Yang Jianwei18,Wang Qiong19,Qin Baoli20,Pan Hongming21,Zhang Jun22ORCID,Bai Xianhong23,Zheng Qingshan24

Affiliation:

1. Cancer Center of Jinling Hospital, Nanjing, China

2. Shanghai East Hospital, Shanghai, China

3. Harbin Medical University Cancer Hospital, Harbin, China

4. The First Affiliated Hospital of Bengbu Medical College, Bengbu, China

5. The Second Hospital of Anhui Medical University, Hefei, China

6. Cancer Center of Sun Yat-sen University, Guangzhou, China

7. The Fifth Medical Center, General Hospital of People's Liberation Army, Beijing, China

8. Xijing Hospital, Air Force Medical University of PLA, Xi'an, China

9. Jiangsu Cancer Hospital, Nanjing, China

10. The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

11. Zhongshan Hospital, Fudan University, Shanghai, China

12. National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

13. Zhejiang Cancer Hospital, Institute of Cancer and Basic Medicine, Chinese Academy of Sciences, Cancer Hospital of the University of Chinese Academy of Sciences, Hangzhou, China

14. The First People's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

15. Peking University Cancer Hospital & Institute, Beijing, China

16. Huashan Hospital, Fudan University, Shanghai, China

17. Jilin Cancer Hospital, Changchun, China

18. Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou, China

19. Jiangyin People's Hospital, Jiangyin, China

20. Liaoning Cancer Hospital & Institute, Shenyang, China

21. Sir Run Run Shaw Hospital Zhejiang University School of Medicine, Hangzhou, China

22. Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

23. Biotech Pharmaceutical Ltd, Corp, Beijing, China

24. Shanghai University of Traditional Chinese Medicine, Shanghai, China

Abstract

K-Ras pancreatic cancers benefit overall survival in phase 3 NOTABLE study.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3